| Date | Title | Description | Source |
| 12.02.2024 | MediWound Reports Positive Results In Head-to-head Compariso... | (RTTNews) – MediWound Ltd. (MDWD) Monday reported positive results from head-to-head comparison anal... | ibf.fund/n... |
| 28.12.2023 | DoD awards MediWound $6.7M to develop field-care burn treatm... | MediWound's drug treats eschar removal, replacing the need for surgery
Burns account for an estimate... | vator.tv/n... |
| 13.11.2023 | MediWound Receives Positive CHMP Opinion Recommending Approv... | The label expansion will solidify NexoBrid’s position in the EU as a safe and effective non-surgical... | einpresswi... |
| 07.08.2023 | MediWound to Report Second Quarter 2023 Financial Results | Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time
YAVNE, Isra... | einpresswi... |
| 03.07.2023 | MediWound Receives Positive Scientific Advice from European ... | Affirms the clear path forward for the Company’s global Phase III study of EscharEx in venous leg ul... | einpresswi... |
| 30.05.2023 | MediWound Reports First Quarter 2023 Financial Results and P... | /EIN News/ -- On track to initiate EscharEx® Phase III study in fourth quarter 2023
NexoBrid® U.S. l... | einpresswi... |
| 07.02.2023 | MediWound Announces Closing of $27.5 Million Registered Dire... | - | globenewsw... |
| 05.02.2023 | Billionaire Steve Cohen leads $27.5 million investment in Me... | - | accessindu... |
| 05.02.2023 | Billionaire Steve Cohen leads $27.5 million investment in Cl... | - | accessindu... |
| 23.12.2022 | MediWound Expands NexoBrid’s Global Presence with Marketing ... | /EIN News/ -- Japan is the first country in the world to approve NexoBrid for people of all ages; pe... | einpresswi... |
| 03.11.2022 | MediWound to Report Third Quarter 2022 Financial Results | Conference Call and Webcast Scheduled for Tuesday, November 15, 2022 at 8:30 am Eastern Time
/EIN Ne... | einpresswi... |
| 25.10.2022 | MediWound Announces Formation of Strategic Advisory Board | YAVNE, Israel, Oct. 25, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully integrated b... | globenewsw... |
| 25.10.2022 | MediWound Announces Formation of Strategic Advisory Board | Esteemed group of industry leaders to contribute expertise and experience to MediWound’s strategic a... | einpresswi... |
| 18.10.2022 | MediWound's EscharEx® Featured in Oral and Poster Presentati... | YAVNE, Israel, Oct. 18, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
| 09.10.2022 | MediWound Announces $30M Raise for Clinical Trials and Produ... | MediWound Ltd. (Nasdaq: MDWD), which has developed and markets a burn treatment compound that is und... | ibf.fund/n... |
| 07.10.2022 | MediWound Announces Closing of the Concurrent Registered Dir... | YAVNE, Israel, Oct. 07, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully integrated b... | globenewsw... |
| 20.09.2022 | EMA Accepts MediWound’s Application for Extended Indication ... | YAVNE, Israel, Sept. 20, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a f... | globenewsw... |
| 12.09.2022 | MediWound’s NexoBrid® Highlighted in 45 Posters and Presenta... | YAVNE, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a ful... | globenewsw... |
| 09.08.2022 | MediWound Reports Second Quarter 2022 Financial Results and ... | Positive Results in Two Phase 2 Trials of EscharEx
FDA Assigned PDUFA Target Date of January 1, 2023... | globenewsw... |
| 08.08.2022 | MediWound Enhances Its Board and Executive Leadership Team | Mr. Nachum Shamir appointed as Chairman of the Board
Dr. Robert Snyder appointed as Chief Medical Of... | globenewsw... |
| 03.08.2022 | MediWound Announces U.S. FDA Acceptance of Biologics License... | YAVNE, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a full... | globenewsw... |
| 01.08.2022 | MediWound Schedules Second Quarter 2022 Financial Results | Call Scheduled for Tuesday, August 9, 2022 at 8:30 AM Eastern Time
YAVNE, Israel, Aug. 01, 2022 (GLO... | globenewsw... |
| 11.07.2022 | MediWound Announces Positive Initial Data from its U.S. Phas... | MW005 Shown to Be Safe and Well-Tolerated
Target Lesions Clearance Data Provides Clinical Efficacy P... | globenewsw... |
| 08.07.2022 | MediWound Announces Presentation on EscharEx at the Advanced... | YAVNE, Israel, July 08, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
| 07.07.2022 | MediWound Announces Positive Results from its U.S. Phase 2 P... | EscharEx Showed Safe, Effective and Rapid Debridement in VLUs and DFUs
Data Demonstrates EscharEx Re... | globenewsw... |
| 05.07.2022 | MediWound to Host a Key Opinion Leader Investor Day on Escha... | YAVNE, Israel, July 05, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
| 30.06.2022 | MediWound Names Mr. Tzvi Palash as Chief Operating Officer | YAVNE, Israel, June 30, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
| 17.05.2022 | MediWound Announces CEO Transition | Ofer Gonen, current Board member and CEO of Clal Biotechnology Industries Ltd., appointed as New CEO... | globenewsw... |
| 17.05.2022 | MediWound Reports First Quarter 2022 Financial Results | Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
On track ... | globenewsw... |
| 12.05.2022 | MediWound Announces Positive Results from Its U.S. Phase 2 T... | Study Met Primary and Key Secondary Endpoints with Statistically Significant Results Compared to Con... | globenewsw... |
| 10.05.2022 | MediWound to Report First Quarter Financial Results and Host... | YAVNE, Israel, May 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated bi... | globenewsw... |
| 12.04.2022 | MediWound's EscharEx Highlighted in Poster and Oral Presenta... | YAVNE, Israel, April 12, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated ... | globenewsw... |
| 29.03.2022 | MediWound to Present EscharEx Clinical Data at the Symposium... | Results Highlight the Safety and Efficacy in Hard-to-Heal Wounds
SAWC to Take Place in Phoenix, Ariz... | globenewsw... |
| 22.03.2022 | MediWound Announces Exercise of Over-Allotment Option | YAVNE, Israel, March 22, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a bio... | globenewsw... |
| 21.03.2022 | MediWound Announces Last Patient Out in EscharEx U.S. Phase ... | Primary Endpoint Met with Highly Statistically Significant Results
Final Data Readout Expected in Se... | globenewsw... |
| 10.03.2022 | MediWound to Report Fourth Quarter and Year End 2021 Financi... | YAVNE, Israel, March 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated ... | globenewsw... |
| 10.03.2022 | MediWound Announces Closing of Public Offering of Ordinary S... | YAVNE, Israel, March 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a bio... | globenewsw... |
| 03.03.2022 | MediWound Announces Pricing of Public Offering of Ordinary S... | YAVNE, Israel, March 03, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a bio... | globenewsw... |
| 02.03.2022 | MediWound Ltd. Announces Proposed Public Offering of Ordinar... | YAVNE, Israel, March 02, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“Mediwound”), a bio... | globenewsw... |
| 01.03.2022 | MediWound to Present at Upcoming Investor Conferences in Mar... | YAVNE, Israel, March 01, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated ... | globenewsw... |
| 17.02.2022 | MediWound Awarded a U.S. Department of Defense Research Gran... | YAVNE, Israel, Feb. 17, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
| 10.02.2022 | MediWound Announces Additional $9 Million in Funding from BA... | YAVNE, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | marketscre... |
| 10.02.2022 | Another year, another $9M in BARDA funding for MediWound; Af... | The Israeli biopharma MediWound has landed $9 million in BARDA funding to support the BLA resubmissi... | endpts.com... |
| 10.02.2022 | MediWound : Announces Additional $9 Million in Funding from ... | MediWound Announces Additional $9 Million in Funding from BARDA to Support
NexoBrid BLA Resubmission... | marketscre... |
| 10.02.2022 | MediWound Announces Additional $9 Million in Funding from BA... | YAVNE, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
| 24.01.2022 | MediWound Announces Positive Topline Results From Its U.S. P... | Primary Endpoint Met with Highly Statistically Significant Results
No Observed Safety Issues
Final D... | globenewsw... |
| 24.01.2022 | MediWound Announces Positive Topline Results From Its U.S. P... | Primary Endpoint Met with Highly Statistically Significant Results
No Observed Safety Issues
Final D... | marketscre... |
| 20.12.2021 | MediWound Announces Positive Initial Data from its U.S. Phas... | Data Demonstrate EscharEx Reduces Biofilm and Bacterial Burden
EscharEx is Shown to be Safe with No ... | globenewsw... |
| 18.11.2021 | EMA Provides Regulatory Path for Pediatric Label Extension f... | YAVNE, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fu... | globenewsw... |
| 16.11.2021 | MediWound Reports Third Quarter 2021 Financial Results | Third Quarter Revenues of $6.4 Million; Year-to-Date 2021 Revenues Increased 21%
Clarity on Regulato... | globenewsw... |
| 04.11.2021 | MediWound to Report Third Quarter 2021 Financial Results and... | YAVNE, Israel, Nov. 04, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated b... | globenewsw... |
| 04.10.2021 | MediWound : Announces Peer-Reviewed Publication of EscharEx ... | EscharEx Treatment Demonstrated Superior Efficacy in Debridement of Eschar
YAVNE, Israel, Oct. 04, 2... | marketscre... |
| 09.07.2021 | MediWound Announces Peer-Reviewed Paper Detailing EscharEx P... | Study Findings Demonstrate Strong Results in Debriding Venous Leg Ulcers and Diabetic Foot Ulcers
In... | marketscre... |
| 29.06.2021 | MediWound Receives Complete Response Letter from U.S. FDA fo... | YAVNE, Israel, June 29, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | marketscre... |
| 07.06.2021 | MEDIWOUND LTD.
MediWound Announces Peer-Reviewed Paper of a... | Findings Provide Preliminary Proof-of-Concept
Phase I/II Clinical Study in Basal Cell Carcinoma Sche... | marketscre... |
| 19.05.2021 | MEDIWOUND LTD.
MediWound : Notice of Annual General Meeting... | MEDIWOUND LTD.
42 Hayarkon Street, Yavne 8122745, Israel
May 5, 2021
_______________________________... | marketscre... |
| 19.05.2021 | MEDIWOUND LTD.
MediWound : Proxy Statements | MEDIWOUND LTD.
42 Hayarkon Street, Yavne 8122745, Israel
972 77 971 4100
__________________________
... | marketscre... |
| 24.03.2021 | MediWound Hosting Analyst Day Webinar on EscharEx – Enzymati... | YAVNE, Israel, March 24, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated ... | marketscre... |
| 25.02.2021 | MediWound Reports Fourth Quarter and Full-Year 2020 Financia... | Fourth Quarter Revenues of $6.7 Million - Up 23%
and Full-Year 2020 Revenues of $21.8 Million - Prod... | globenewsw... |
| 10.02.2021 | MediWound to Participate in the BTIG Virtual MedTech, Digita... | YAVNE, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated b... | globenewsw... |
